Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib

Background: Prostate cancer is one of the most common cancers diagnosed in developed countries. Many studies have confirmed that the nm23 gene suppresses metastasis in different types of cancers. The effects of, imatinib as the first member of tyrosine kinases inhibitors, were showed in research and...

Full description

Bibliographic Details
Main Authors: Seyed Ataollah Sadat-Shandiz, Mehdi Shafiee-Ardestani, Shiva Irani, Delavar Shahbazzadeh
Format: Article
Language:fas
Published: Isfahan University of Medical Sciences 2015-01-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/4602
_version_ 1797725328925261824
author Seyed Ataollah Sadat-Shandiz
Mehdi Shafiee-Ardestani
Shiva Irani
Delavar Shahbazzadeh
author_facet Seyed Ataollah Sadat-Shandiz
Mehdi Shafiee-Ardestani
Shiva Irani
Delavar Shahbazzadeh
author_sort Seyed Ataollah Sadat-Shandiz
collection DOAJ
description Background: Prostate cancer is one of the most common cancers diagnosed in developed countries. Many studies have confirmed that the nm23 gene suppresses metastasis in different types of cancers. The effects of, imatinib as the first member of tyrosine kinases inhibitors, were showed in research and treatment of solid tumors. The aim of the current study was to investigate the effect of imatinib on cell viability and suppressor metastasis nm23 gene expression in prostate cancer cell line. Methods: In this study, prostate cancer (PC-3) human cell line was treated with various concentrations of imatinib for 48 hours. Cell viability was assessed using MTT assay [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and the half maximal inhibitory concentration (IC50) value was determined. We extracted RNA molecules via using RNX solution, after which cDNA was synthesized. The precise primers for the nm23 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes were designed via specific software. Then, the quantity of nm23 compared to GAPDH gene (reference gene) was analyzed using real-time polymerase chain reaction (PCR) method. Findings: Imatinib exerted an inhibitory effect on the viability of metastatic PC-3 cells. The calculated nm23/GAPDH gene expression ratio was 1.62 ± 0.02 (P < 0.01) in 21/33 mM concentration of imatinib at 48 hours. Conclusion: The results of this study showed that imatinib can inhibit metastasis via upregulating nm23 gene expression in prostate cancer adenocarcinoma PC-3 cell line.
first_indexed 2024-03-12T10:29:36Z
format Article
id doaj.art-4a3488bb27374c0387fd814875b0fcf7
institution Directory Open Access Journal
issn 1027-7595
1735-854X
language fas
last_indexed 2024-03-12T10:29:36Z
publishDate 2015-01-01
publisher Isfahan University of Medical Sciences
record_format Article
series مجله دانشکده پزشکی اصفهان
spelling doaj.art-4a3488bb27374c0387fd814875b0fcf72023-09-02T09:20:36ZfasIsfahan University of Medical Sciencesمجله دانشکده پزشکی اصفهان1027-75951735-854X2015-01-0132309190719171734Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with ImatinibSeyed Ataollah Sadat-Shandiz0Mehdi Shafiee-Ardestani1Shiva Irani2Delavar Shahbazzadeh3PhD Student, Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.Assistant Professor, Department of Radiopharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, IranAssistant Professor, Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, IranAssociate Professor, Biotechnology Research Center, Pasteur Institute of Iran AND Medical Biotechnology Group, Venom and Toxin Lab, Tehran, IranBackground: Prostate cancer is one of the most common cancers diagnosed in developed countries. Many studies have confirmed that the nm23 gene suppresses metastasis in different types of cancers. The effects of, imatinib as the first member of tyrosine kinases inhibitors, were showed in research and treatment of solid tumors. The aim of the current study was to investigate the effect of imatinib on cell viability and suppressor metastasis nm23 gene expression in prostate cancer cell line. Methods: In this study, prostate cancer (PC-3) human cell line was treated with various concentrations of imatinib for 48 hours. Cell viability was assessed using MTT assay [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] and the half maximal inhibitory concentration (IC50) value was determined. We extracted RNA molecules via using RNX solution, after which cDNA was synthesized. The precise primers for the nm23 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes were designed via specific software. Then, the quantity of nm23 compared to GAPDH gene (reference gene) was analyzed using real-time polymerase chain reaction (PCR) method. Findings: Imatinib exerted an inhibitory effect on the viability of metastatic PC-3 cells. The calculated nm23/GAPDH gene expression ratio was 1.62 ± 0.02 (P < 0.01) in 21/33 mM concentration of imatinib at 48 hours. Conclusion: The results of this study showed that imatinib can inhibit metastasis via upregulating nm23 gene expression in prostate cancer adenocarcinoma PC-3 cell line.http://jims.mui.ac.ir/index.php/jims/article/view/4602Imatinibnm23Prostate cancerMetastasis
spellingShingle Seyed Ataollah Sadat-Shandiz
Mehdi Shafiee-Ardestani
Shiva Irani
Delavar Shahbazzadeh
Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib
مجله دانشکده پزشکی اصفهان
Imatinib
nm23
Prostate cancer
Metastasis
title Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib
title_full Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib
title_fullStr Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib
title_full_unstemmed Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib
title_short Upregulation of Nm23, a Metastasis Suppressor Gene, in Human Prostate Adenocarcinoma (PC-3) Cell Line Treated with Imatinib
title_sort upregulation of nm23 a metastasis suppressor gene in human prostate adenocarcinoma pc 3 cell line treated with imatinib
topic Imatinib
nm23
Prostate cancer
Metastasis
url http://jims.mui.ac.ir/index.php/jims/article/view/4602
work_keys_str_mv AT seyedataollahsadatshandiz upregulationofnm23ametastasissuppressorgeneinhumanprostateadenocarcinomapc3celllinetreatedwithimatinib
AT mehdishafieeardestani upregulationofnm23ametastasissuppressorgeneinhumanprostateadenocarcinomapc3celllinetreatedwithimatinib
AT shivairani upregulationofnm23ametastasissuppressorgeneinhumanprostateadenocarcinomapc3celllinetreatedwithimatinib
AT delavarshahbazzadeh upregulationofnm23ametastasissuppressorgeneinhumanprostateadenocarcinomapc3celllinetreatedwithimatinib